Clinical outcomes in 2003-33 and 2006-66 trials according to gene expression profiling (GEP)–defined risk. (A-D) Low-risk disease: OS (A), EFS, (B), CR onset (C), and CRD (D). (E-H) High-risk disease: OS (E), EFS, (F), CR onset (G), and CRD (H).